During the past decade, Whittingham Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Whittingham Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 10 trials, followed by "Novartis Pharmaceuticals" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "SciClone Pharmaceuticals" with 2 trials sponsored and "Seagen Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Whittingham Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Grupo Espanol de Investigacion del Cancer de Mama" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Whittingham Cancer Center" are "Head and Neck Cancer" (3 trials), "Pancreatic Cancer" (3 trials), "Prostate Cancer" (3 trials), "Breast Cancer" (2 trials) and "Lymphoma, Non-Hodgkin" (2 trials). Many other conditions were trialed in "Whittingham Cancer Center" in a lesser frequency.

Most popular intervention types in "Whittingham Cancer Center" are "Drug" (27 trials), "Radiation" (8 trials), "Biological" (3 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "radiation therapy" (3 trials), "SCV-07" (2 trials), "brachytherapy" (2 trials) and "docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Whittingham Cancer Center" are 24 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Whittingham Cancer Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Whittingham Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Whittingham Cancer Center, 5 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".